Clinical Trial Update: A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

View source ↗

Summary

A long-term safety study of infliximab in patients with moderate to severe COPD has completed, with the document summarizing the safety results from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: COPD, Pulmonary Disease, Chronic Obstructive | Status: COMPLETED